Inflammatory Bowel Disease Treatment in India for International Patients

GetWellGo helps international patients access advanced Inflammatory Bowel Disease treatment in India with specialized doctors & cost-effective care.

Inflammatory Bowel Disease Treatment in India for International Patients

  • Category

    General

  • Published By

    GetWellGo Team

  • Updated on

    20-Aug-2025

Inflammatory bowel disease treatment in India

IBD, which is characterized by Crohn disease and ulcerative colitis, is a chronic disorder that has no full treatment, but management is to decrease inflammation, manage the symptoms, and prevent relapse. Treatment varies because of the severity, location and complications of any disease as well as the patient reaction.

This is a summary of the treatment with IBD:

Medications

Anti-inflammatory drugs:

  • Aminosalicylates (5-ASA): e.g. mesalamine, sulfasalazine.
  • It has been commonly employed in mild to moderate ulcerative colitis.
  • Corticosteroids: e.g. prednisone, budeoside.
  • Temporarily to relieve flare-ups; not viable in the long-term because of side effects.

Supressors of immune system:

  • Azathioprine, 6-mercaptopurine, methotrexate - lower activity of the immune system.
  • Assist in prolonging the remissions and decreasing steroid dependency.

Advanced therapy (Biologics):

  • Anti-TNF: infliximab, adalimumab, certolizumab.
  • Anti-integrinves: vedolizumab.
  • Anti-interleukin 12/23: ustekinumab.
  • Applied as a lay-to-severe IBD or other treatment failure.

Newer oral drugs- JAK inhibitors:

  • Tofacitinib (ulcerative colitis).
  • Works prevent the action of certain routes of immune systems.

Antibiotics:

  • Sometimes applies to Crohn disease to treat abscesses, fistulas or bacterial overgrowth.

Nutritional / Lifestyle management

  • Special diets (low-FODMAP / low-residue / personalized diets).
  • Proper hydration, vitamins and minerals (B12, D, iron and calcium).
  • ---Avoidance of trigger foods (spicy, fatty, processed foods, caffeine, alcohol).
  • Stress plays (see mitigation), physical activity, and smoking assertion (particularly in Crohn).

Surgery

  • Indication when medication is unresponsive or complications occur (e.g. bowel obstruction, perforation, abscess, intensive bleeding).
  • Ulcerative colitis: colon (proctocolectomy) may eradicate the illness.
  • Crohn disease: Surgery: operations to remove damaged areas do not heal Crohn disease and risk the disease to reoccur.

Supportive and Adjunct to Therapies

  • Non-NSAIDs pain treatment.
  • In certain cases probiotics.
  • Cognitive support (IBD associated with anxiety/depression).

Best hospitals for inflammatory bowel disease in India

Inflammatory bowel disease specialist doctors in India

Top gastroenterologists in India for IBD:

Factors Affecting Inflammatory bowel disease treatment cost in India

This is the current breakdown of the factors which influence the cost of treating Inflammatory Bowel Disease (IBD) in India according to recent numbers and real-life experience:

Kind of Drugs

  • Biologic therapies (e.g. Belumimab, Adalimumab, Vedolizumab, Tofacitinib) biologic therapies can be the most costly choice of medications
  • The cost of conventional treatments (5-ASA, steroids, immune modulators (azathioprine)) is considerably lower yet; in general, the duration of treatment is longer 

Disease Stage: Active former Remission

  • Costs spiked primarily due to drugs; hospitalizations accounted for 20–23% of total costs, and productivity losses added another ~16–18%

Hospitalization, Investigations and Procedures

  • Diagnostic activities differ in price
  • Prolonged hospitalizations, surgical procedures and continued observation play a significant part in costs, more so on advanced or complex-cases.

Geography, Care Facility Type

  • Govt/public venues will be less expensive but potentially limited specialist access (and longer wait times) (particularly non-metro regions).
  • Compared to open or public hospitals, faster access and sophisticated care are given in the form of higher payments to private hospitals.

Biosimilars Access

  • Biosimilars (of Infliximab and Adalimumab) may achieve cost-savings considerably compared with originators, but it remains inaccessible particularly in non- metropolitan areas 

Diagnostic Uncertainties

  • Delay though uncertainty about the diagnosis is not directly related to the diagnostic test cycle, the uncertainty may cause a delay in the system.
  • Diagnosis is complicated by endemic infection such as intestinal tuberculosis and it takes time to begin the right management of IBD. Delays affect both acceleration of the disease, and the subsequent cost of the disease and costs

Advanced inflammatory bowel disease treatment India

Advanced treatment of Inflammatory Bowel Disease (IBD) is typically reserved when the conventional treatments (5-ASA, steroids, immunomodulators) fail to manage the disease or when the patients experience moderate-to-severe or refractory IBD (both Crohn’s disease and Ulcerative colitis).

The following is an organizational outline:

Mainstay of Advanced Treatment: Biologic Therapies (Mainstay of Advanced Treatment)

These are the antibodies being synthesized in the laboratory and which are directed at definite inflammation pathways.

Anti-TNF agents:

  • Infliximab, Adalimumab, Certolizumab pegol, Golimumab
  • Inhibit a key IBD inflammatory protein called TNF-a.
  • Useful in remission induction and remission maintenance, sealing fistulas (Crohn), and in the reduction of hospitalizations.
  • Risks: infection (TB, hepatitis) lymphoma (rare).

Anti-integrin therapy:

  • Vedolizumab (gut-specific)
  • Blocks influx of immune cells along the intestinal wall.
  • More specific, less systemic side effects compared with anti-TNFs.
  • Particularly helpful when the patients do not respond to anti-TNFs.

Anti-interleukin therapy:

  • Ustekinumab (inhibits IL -12 and IL -23)
  • Was effective in Crohn and ulcerative colitis.
  • Is able to work in biologic-refractory patients.

Small Molecule Therapies (Advanced Medications Oral)

JAK inhibitors:

  • Tofacitinib (UC), Upadacitinib (CD/UC, new approvals)
  • Jak pathways blockage oral pills that curtail immune hyperactivity.
  • Desperate measures (act immediately i.e. some patients may respond within days).
  • Risks: activation of herbeszoster, blood thrombosis (as an exception), elevated cholesterol.

S1P modulators receptors:

  • Ozanimod (approved UC)
  • Blocks access of white blood cells to the gut.
  • Easy and oral and mostly well tolerated.

Advanced Surgery Options

Ulcerative Colitis:

  • Total porctocolectomy plus ileal pouch-anal anatomy(IPAA) = curative.

Crohn’s Disease:

  • Limited resections, stricturoplasty, or the placement of a seton in fistulas.
  • No curative solution is possible but surgery facilitates the management of the complications.

Combination Therapies

  • Biologics + Immunomodulators (azathioprine, methotrexate):
  • lessen the production of antibodies to biologics enhancing long-term performance.
  • Top-down/step-up according to severity and patient profile.

Personalised and Emerging Therapies

  • Therapeutic drug monitoring (TDM): modification of the dose of biologic therapy according to the level in the blood.
  • Fecal microbiota transplantation (FMT): Clinical trial, UC some benefit.
  • Stem cell therapy: Allogeneic mesenchymal stem cells are used in the treatment of refractory perianal Crohn (s).
  • Precision medicine: Treatment tailored with respect to genetics/biomarkers (ongoing research).

Inflammatory bowel disease treatment India by GetWellGo

GetWellGo does have work in the gastroenterology department (in which IBD treatment is performed) and can help with access to hospitals that provide such care. They liaise with well-known multi-speciality/ super speciality hospitals around India, which include but are not limited to Medanta, Fortis, Max, Manipal, Artemis, CARE, KIMS Health, and Marengo Hospital.

Why Choose GetWellGo for Inflammatory Bowel Disease Treatment?

GetWellGo is regarded as a leading supplier of healthcare services. We help our foreign clients choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for Inflammatory Bowel Disease treatment.
  • Expert gastroenterologists with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food

Recent Blogs